175 related articles for article (PubMed ID: 33433931)
1. A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis.
Pendergrast J; Armali C; Callum J; Cserti-Gazdewich C; Jiwajee A; Lieberman L; Lau W; Lin Y; Parmar N; Pavenski K; Riden LS; Shehata N; Willie-Ramharack K; Tomlinson G; Tong TN; Binnington B; Branch DR;
Transfusion; 2021 Apr; 61(4):1053-1063. PubMed ID: 33433931
[TBL] [Abstract][Full Text] [Related]
2. Hemolysis upon intravenous immunoglobulin transfusion.
Padmore RF
Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
[TBL] [Abstract][Full Text] [Related]
3. The role of inflammation in intravenous immune globulin-mediated hemolysis.
Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR
Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports.
Padmore R
Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898
[TBL] [Abstract][Full Text] [Related]
5. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.
Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM
Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192
[TBL] [Abstract][Full Text] [Related]
6. Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility.
Mielke O; Fontana S; Goranova-Marinova V; Shebl A; Spycher MO; Wymann S; Durn BL; Lawo JP; Hubsch A; Salama A
Transfusion; 2017 Nov; 57(11):2629-2638. PubMed ID: 28840942
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012.
Berg R; Shebl A; Kimber MC; Abraham M; Schreiber GB
Transfusion; 2015 Jul; 55 Suppl 2():S36-46. PubMed ID: 26174896
[TBL] [Abstract][Full Text] [Related]
8. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and mechanisms of antibody-mediated hemolysis.
Flegel WA
Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.
Cuesta H; El Menyawi I; Hubsch A; Hoefferer L; Mielke O; Gabriel S; Shebl A
Transfusion; 2022 Sep; 62(9):1894-1907. PubMed ID: 35916266
[TBL] [Abstract][Full Text] [Related]
11. ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.
Branch DR; Hellberg Å; Bruggeman CW; Storry JR; Sakac D; Blacquiere M; Tong TN; Burke-Murphy E; Binnington B; Parmar N; Riden LS; Willie K; Armali C; Aziz J; Lieberman L; Laroche V; Callum J; Lin Y; Shehata N; Pavenski K; Lau W; Hannach B; Kuijpers TW; Olsson ML; Cserti-Gazdewich C; Pendergrast J
Blood; 2018 Feb; 131(7):830-835. PubMed ID: 29305554
[No Abstract] [Full Text] [Related]
12. The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin-associated hemolysis.
Tong TN; Blacquiere M; Sakac D; Burke-Murphy E; Yi Q; Callum J; Cserti-Gazdewich C; Parmar N; Shehata N; Pavenski K; Lau W; Lin Y; Lieberman L; Branch DR; Pendergrast J
Transfusion; 2020 Dec; 60(12):3010-3018. PubMed ID: 33091964
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment.
Taylor E; Vu D; Legare C; Keene D
Transfusion; 2015 Jul; 55 Suppl 2():S23-7. PubMed ID: 26174894
[TBL] [Abstract][Full Text] [Related]
14. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
Thorpe SJ
Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
Welsh KJ; Bai Y
J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
[TBL] [Abstract][Full Text] [Related]
16. Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial.
Akman AO; Kara FK; Koksal T; Cakir BC; Karagol C; Sayli T
Transfus Apher Sci; 2017 Aug; 56(4):531-534. PubMed ID: 28818402
[TBL] [Abstract][Full Text] [Related]
17. An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG).
Wang Y; Khalenkov A; Scott DE
Biologicals; 2022 Jul; 78():1-9. PubMed ID: 35842374
[TBL] [Abstract][Full Text] [Related]
18. The role of isoagglutinins in intravenous immunoglobulin-related hemolysis.
Bellac CL; Hottiger T; Jutzi MP; Bögli-Stuber K; Sänger M; Hanschmann KM; Keller-Stanislawski B; Funk MB
Transfusion; 2015 Jul; 55 Suppl 2():S13-22. PubMed ID: 26174892
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment.
Gerber S; Gaida A; Spiegl N; Wymann S; Antunes AM; Menyawi IE; Zurbriggen B; Hubsch A; Imboden M
BioDrugs; 2016 Oct; 30(5):441-451. PubMed ID: 27646589
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
